Teaching Loved Ones to Help Veterans Optimize Their PTSD Care and Healing
1 other identifier
interventional
28
1 country
3
Brief Summary
PTSD occurs in as many as 17% of US military Veterans and is associated with a host of negative, long-term consequences to the individual, their families, and society at large. EBPs, such as Prolonged Exposure, result in clinically significant symptom relief for many. Yet, these therapies have proven less effective for military personnel and Veterans and treatment dropout rates are high. The investigators' team surveyed Veterans initiating EBPs for PTSD and a family member across four VA medical centers (N = 598; Project HomeFront). The investigators found that Veterans were more than twice as likely to complete EBPs when loved ones encouraged them to confront distress and that Veterans experienced greater treatment gains when they shared more with their loved ones about their treatment. A couples-based, exposure therapy for PTSD that integrates intimate partners into every session of PE could provide the opportunity to mobilize the whole household in the service of EBP engagement, while extending the goals of therapy beyond symptom reduction to family functioning. The investigators anticipate this intervention will teach couples to embrace a lifestyle that supports confronting trauma-related distress, so the Veteran and his/her family can achieve optimal functional outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2020
CompletedFirst Posted
Study publicly available on registry
January 27, 2020
CompletedStudy Start
First participant enrolled
November 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedResults Posted
Study results publicly available
July 1, 2024
CompletedJuly 1, 2024
March 1, 2024
1.7 years
January 22, 2020
June 8, 2023
March 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinician Administered PTSD Scale for DSM-5 to Assess Changes in PTSD Symptoms.
Structured clinical interview assessing symptoms of PTSD. CAPS-5 is a 30-item questionnaire, corresponding to the DSM-5 diagnosis for PTSD. CAPS-5 total symptom severity score is calculated by summing severity scores for the 20 DSM-5 PTSD symptoms. Similarly, CAPS-5 symptom cluster severity scores are calculated by summing the individual item severity scores for symptoms corresponding to a given DSM-5 cluster: Criterion B (items 1-5); Criterion C (items 6-7); Criterion D (items 8-14); and, Criterion E (items 15-20). A symptom cluster score may also be calculated for dissociation by summing items 19 and 20. Severity scores range from 0 to 80 and higher scores correspond with more severe symptoms of PTSD.
Up to 26 weeks post baseline
Study Arms (1)
Loved one assisted treatment
EXPERIMENTALThe investigators propose to bring a loved one into PE, one of the most researched and efficacious treatments for PTSD, to increase support for PE adherence. The intervention is a 13-session cognitive-behavioral, intimate partner-assisted treatment for PTSD that draws from PE, ICBT, and PE2.
Interventions
The investigators propose to bring a loved one into PE, one of the most researched and efficacious treatments for PTSD, to increase support for PE adherence. The intervention is a 13-session cognitive-behavioral, intimate partner-assisted treatment for PTSD that draws from PE, ICBT, and PE2.
Eligibility Criteria
You may qualify if:
- Enrolled in VHA care
- Clinically significant PTSD symptoms
- Have a LO (loved one/intimate partner) with whom they have been in a romantic relationship with for 6 months
- Will allow a LO to participate
- Willing to be seen via telehealth when in-person treatment options aren't available.
You may not qualify if:
- Actively suicidal/homicidal with intent and/or plan
- Episode of mania/ psychosis in past 3 months
- Severe substance use problem in past 3 months
- Moderate relationship violence
- Veteran has underlying medical condition or a planned medical procedure likely to impair ability to engage in treatment.
- LO screens positive for PTSD
- Veteran and/or LO fails to complete baseline survey
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Atlanta VA Medical and Rehab Center, Decatur, GA
Decatur, Georgia, 30033, United States
VA Ann Arbor Healthcare System, Ann Arbor, MI
Ann Arbor, Michigan, 48105, United States
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota, 55417, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Small number of subjects analyzed
Results Point of Contact
- Title
- Laura Meis, PhD
- Organization
- Center for Care Delivery & Outcomes Research
Study Officials
- PRINCIPAL INVESTIGATOR
Laura A. Meis, PhD
Minneapolis VA Health Care System, Minneapolis, MN
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2020
First Posted
January 27, 2020
Study Start
November 2, 2020
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
July 1, 2024
Results First Posted
July 1, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share